Farchemia

Farchemia is a prominent Italian contract development and manufacturing organization (CDMO) that specializes in the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for the global pharmaceutical industry. Established in 1962 and headquartered in Treviglio, Italy, the company offers comprehensive services ranging from process optimization and pilot-scale production to full-scale commercial manufacturing under cGMP conditions. In 2011, Farchemia was acquired by the International Chemical Investors Group (ICIG) and integrated into its WeylChem fine chemicals platform. The facility is regularly inspected by major regulatory bodies, including the FDA and AIFA, ensuring high-quality standards for its diverse portfolio of generic and custom-manufactured chemical entities.